
Peroxfarma
AI Verified
Spain
Family Office
Spain
1977
Criteria | Requirements | Match |
---|---|---|
Regions | Southern Europe |
00
|
Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Impact Area |
00 00 00
|
|
Stage | Series A |
00
|
Ticket size |
00 00 00
-
00 00 00
USD
|
00
|
Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Min. revenue |
00 00 00
USD
|
00
|
Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company description
Peroxfarma stands as a distinguished pharmaceutical enterprise with a remarkable forty-year legacy dedicated to enhancing human health and wellbeing. Throughout its journey, the company has successfully developed and strengthened its market-leading brands, many of which have achieved dominant positions in their respective segments. These premium offerings embody the organization's core principles and demonstrate its unwavering dedication to healthcare excellence. The values that drive Peroxfarma permeate every aspect of its operations, from day-to-day activities to major corporate milestones, fostering increasing trust among consumers and industry partners alike.
What truly distinguishes Peroxfarma within the competitive pharmaceutical landscape is its exceptional commitment to customer-centric innovation. The company maintains close collaborative relationships with its clients, consistently delivering innovative solutions characterized by flexibility and responsiveness. This approach is facilitated through interdisciplinary teams that bring together diverse expertise and encourage creative thinking, enabling Peroxfarma to maintain a forward-looking perspective that anticipates market needs. This collaborative methodology has proven instrumental in helping the organization maximize its capabilities and maintain its competitive edge in a rapidly evolving industry.
Since its inception, Peroxfarma has demonstrated an unwavering commitment to advancing healthcare solutions. The company made healthcare history with its groundbreaking introduction of the first digital electronic blood pressure monitor, a revolutionary development that transformed cardiovascular disease prevention and monitoring. This milestone exemplifies Peroxfarma's longstanding tradition of developing products that address critical healthcare challenges while improving diagnostic capabilities for both healthcare professionals and patients. The innovation represented a significant leap forward in making vital health monitoring more accessible and accurate.
Today, Peroxfarma continues to strengthen its dedication to research and development across all its business divisions, focusing on creating solutions that meaningfully enhance quality of life. The company's excellence, innovation, and social responsibility principles guide its strategic direction and product development initiatives. As healthcare challenges evolve globally, Peroxfarma remains positioned at the forefront of pharmaceutical innovation, leveraging its extensive experience and forward-thinking approach to address emerging health concerns. The organization's continued investment in cutting-edge technologies and methodologies reflects its enduring mission to transform healthcare outcomes through scientific advancement and patient-focused solutions.
Highlights
Ready to raise better?
Create your Free Account!
Frequently asked questions
Peroxfarma maintains its global headquarters in Spain, serving as the strategic center for its operations. The company's primary corporate offices are located at Spain.
Peroxfarma focuses its investment activities on companies operating in the following stages: Series A. Peroxfarma provides strategic capital and expertise to support promising businesses at these critical phases of development.
Peroxfarma maintains a strategic global investment presence, actively seeking opportunities across the following key regions: Southern Europe.
Peroxfarma was established in 1977, marking the beginning of its journey as an investment firm.
Peroxfarma is the following type of investment firm: Family Office. The organization provides capital and strategic support to entrepreneurs and growing companies.